No abstract

Background: The botanical Latin name of the plant, Turnera aphrodisiaca, describes its ancient use as an aphrodisiac.Methods: The aim of the present study is to evaluate the protective effect of ethanolic and aqueous extract of Turnera aphrodisiaca leaves against carbon tetrachloride (CCl4)-induced liver damage in male Wistar rats.Results: Administration with ethanolic and aqueous extract of Turnera aphrodisiaca leaves (200 and 400 mg/kg) for 7 days significantly reduced the impact of CCl4 toxicity on the serum markers of liver damage, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase in a dose dependent matter. In addition, treatment of both the extracts resulted in markedly increased the levels of superoxide dismutase and catalase enzymes in rats. The histopathological studies in the liver of rats also supported that both extracts markedly reduced the toxicity of CCL4 and preserved the histoarchitecture of the liver tissue to near normal.Conclusion: Thus, the results suggest that ethanolic and aqueous extract of  Turnera aphrodisiaca leaves acts as a potent hepatoprotective agent against CCl4 induced hepatotoxicity in rats.

Objectives: The medications of plant-based, herb-mineral, and animal sources have been used by the conventional medics to maintain well-being and care for diseases ever since ancient times. The current study aimed to evaluate the acute and subacute toxicities of the ethanolic extract of Turnera aphrodisiaca (TA) leaves in albino rats. Methods: The acute toxicity studies were carried out where the maximum dosage of 5000 mg/kg body mass was used. The outcome reported for 24 h and singly daily for 2 weeks. The rats were weighed and a range of interpretations, for example, behavior, lesions, mortality, or any indication of sickness, was carried out daily once throughout the study. For the subacute study, four groups of ten animals (female rats) received 10% Tween 20 in distilled H2O (as control), and 250, 500, and 1000 mg/kg of newly developed extracts, correspondingly, every 24th h orally for about 4 weeks. At the ending of every study, hematological study and biochemical parameters were assessed. Results: No major variations (p>0.05) were experienced in the comparative organs, body mass, hematological, biochemical parameters, and offensive malfunctions, in comparison to control, with no mortality reported. Hence, the results of the study may direct the outcome that the intermediate-period oral administration of the TA leaves for 4 weeks does not produce toxicity. Conclusion: Due to these results, we may well wrap up that leaves of TA extract are non-toxic in all doses considered in this study and did not created any obvious signs in the acute and subacute oral toxicity studies.

No abstract